About this trial
It has been demonstrated that sexual activity was common in the majority of men over 50 years old and was an important component of overall quality of life (QoL). Ejaculatory dysfunction (EjD) is the most common side effect of surgical treatment of benign prostatic obstruction (BPO). It has been considered for decades to be an inevitable consequence of restoring micturition comfort. EjD can have a substantial deleterious effect on the QoL of men with previously maintained regular sexual activity, inducing decreased orgasmic intensity and increased levels of anxiety and depression. A better understanding of the physiology of ejaculation has enabled the emergence of modified surgical techniques that aim to preserve antegrade ejaculation. Our hypothesis is that conservation of ejaculation can be achieved by modified surgical procedures without compromising functional outcomes.
Eligibility criteria
Qualifiers
Man over 40 years old
Indication of surgical management for BPH
Prostate volume ≥30 cc and ≤150 cc as evaluated by ultrasonography ( or an MRI if available)
IPSS score ≥12
Disqualifiers
Unwillingness to accept the treatment
No pre-operative ejaculation or sexuality
Neurological pathology responsible for micturition disorders
History of prostatic surgery
Trial design
Treatments tested in this trial
- Partial surgery preserving the prostatic apex
- Conventional endoscopic prostatic surgery